Clinical Trials Directory

Trials / Terminated

TerminatedNCT00523120

Topical Voltaren in Otitis Externa

Topical Voltaren as an Alternative Treatment for Otitis Externa

Status
Terminated
Phase
Phase 2
Study type
Interventional
Enrollment
20 (actual)
Sponsor
Sieff Medical Center · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

Voltaren being a Non-steroidal anti-inflammatory drug (NSAID) drug may be used as a single drug therapy in otitis externa being both therapeutic and analgesic thus reducing consumption of oral analgesia.

Detailed description

anticipated advantages are: reduction of inflammation and edema, no fungal overpopulation- when steroids are employed, contains boric acid as an ingredient, high safety profile, can be switched to antibiotic therapy later, can be used in conjunction wit steroids

Conditions

Interventions

TypeNameDescription
DRUGdiclofenac sodiumtopical solution used in ear 5 drops 8 3/day
DRUGdexotcaural drops

Timeline

Start date
2008-09-01
Primary completion
2011-12-01
Completion
2011-12-01
First posted
2007-08-30
Last updated
2016-04-20

Locations

1 site across 1 country: Israel

Source: ClinicalTrials.gov record NCT00523120. Inclusion in this directory is not an endorsement.

Topical Voltaren in Otitis Externa (NCT00523120) · Clinical Trials Directory